A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Foscarbidopa | CAS 1907685-81-7 - Request Quote

Picture of Foscarbidopa

Foscarbidopa

SZ CAT No:SZ-F133001
CAS No
1907685-81-7
Mol.F.
C10H15N2O7P
Mol.Wt.
306.2
Inv. Status
Synthesis on demand
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Foscarbidopa is chemically (S)-2-Hydrazinyl-3-(3-hydroxy-4-(phosphonooxy)phenyl)-2-methylpropanoic acid. Foscarbidopa is supplied with detailed characterization data compliant with regulatory guideline. Foscarbidopa can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Foscarbidopa.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1907685-81-7

Purchase 1907685-81-7

Order 1907685-81-7

Enquire 1907685-81-7

price of 1907685-81-7

1907685-81-7 Supplier

1907685-81-7 Manufacturer

1907685-81-7 Exporter

buy high quality Foscarbidopa

Purchase Foscarbidopa

Foscarbidopa suppliers

Foscarbidopa manufacturers

Foscarbidopa price

Order Foscarbidopa

Enquire Foscarbidopa

Foscarbidopa cost

Foscarbidopa Supplier

Foscarbidopa Distributor

Foscarbidopa for Method Validation

Foscarbidopa Reference Standard

Foscarbidopa for ANDA Filing

Foscarbidopa for Forced Degradation Studies

Foscarbidopa Identification Standards

Foscarbidopa for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,